Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:11 PM UTC
| NCT Number | NCT05025605 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE1 |
| Target Enrollment | 140 participants |
| Active Locations | 5 sites in the US |
| Sponsor | BioXcel Therapeutics Inc |
| Last Updated on CT.gov | August 11, 2026 (Aug 11, 2026) |
As of October 15, 2026: Clinical trial NCT05025605 is currently recruiting participants. This phase1 study for schizophrenia is actively seeking new participants at 5 locations across the United States. The study is sponsored by BioXcel Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05025605 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05025605 was last updated Aug 11, 2026 (August 11, 2026). HelloStudys verifies this status automatically.